XRX
45
4
D
43
-2
ORCL
28
3
BAC
75
-3
APA
48
-5
AME
66
-3
MCO
64
2
GE
70
-2
XOM
40
-8
CNP
55
-2
ORLY
40
-4
PVH
42
-2
COF
67
2
APD
47
-2
HD
31
-3
XEL
39
-2
EMC
54
-2
GPC
57
-4
TXT
63
-5
JBHT
63
-2
XRX
45
4
D
43
-2
ORCL
28
3
BAC
75
-3
APA
48
-5
AME
66
-3
MCO
64
2
GE
70
-2
XOM
40
-8
CNP
55
-2
ORLY
40
-4
PVH
42
-2
COF
67
2
APD
47
-2
HD
31
-3
XEL
39
-2
EMC
54
-2
GPC
57
-4
TXT
63
-5
JBHT
63
-2
Financhill
Back

Publicis Groupe SA Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Buy
54

PGPEF
Publicis Groupe SA

Last Price:
$104.50
Seasonality Move:
5.9%
Sell
34

INKT
MiNK Therapeutics, Inc.

Last Price:
$11.91
Seasonality Move:
-18.07%
Buy
54
Publicis Groupe SA (PGPEF) is a Buy

Is Publicis Groupe SA a Buy, Sell or Hold?

  • The current Publicis Groupe SA [PGPEF] share price is $104.50. The Score for PGPEF is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • PGPEF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $11.96. The Score for INKT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PGPEF Stock Price Chart

What is Publicis Groupe SA's stock price today?

  • The Publicis Groupe SA share price today is $104.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PGPEF is experiencing slight buying pressure.

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $11.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing slight selling pressure.

PGPEF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.77 Buy
Relative Strength Index (14 RSI): 98.58 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (96.67 - 101.33) Buy
Bollinger Bands (100): (92.41 - 102.73) Buy

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 47.65 Sell
Chaikin Money Flow: -11714 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.88 - 12.8) Buy
Bollinger Bands (100): (12.31 - 15.41) Sell

PGPEF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 101.71 Buy
20-day SMA: 99.69 Buy
50-day SMA: 97.61 Buy
200-day SMA: 99.92 Buy
8-day EMA: 102.18 Buy
20-day EMA: 100.16 Buy
50-day EMA: 96.49 Buy
200-day EMA: 61.25 Buy

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.29 Sell
20-day SMA: 11.54 Buy
50-day SMA: 12.98 Sell
200-day SMA: 11.84 Buy
8-day EMA: 12.15 Sell
20-day EMA: 12.09 Sell
50-day EMA: 12.72 Sell
200-day EMA: 12.23 Sell

Publicis Groupe SA Earnings Growth & PGPEF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

Publicis Groupe SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):